<DOC>
	<DOCNO>NCT00912080</DOCNO>
	<brief_summary>Method : This multicentric prospective cohort compose patient metastatic breast cancer select tumor 's genomic analysis treat chemotherapy Anthracycline without Taxanes ( 6 cycle FEC 100 ) . The patient include surgery write consent must sign proteomic genomic analysis tumor . Patients `` good signature '' genomic analysis receive standard chemotherapy . Primary objective : - To compare metastasis free survival 5 year cohort patient metastatic breast cancer , select genomic profile tumor receive standard chemotherapy contain Anthracycline , result retrospective study . Secondary Objectives : - Overall survival . - Creation circuit ( transport-extraction-genomic analysis-result ) allow begin chemotherapy within 6 week follow primary surgery . - Histological seric proteomic exploratory study .</brief_summary>
	<brief_title>Utilization Genomic Signature Decision-making Adjuvant Treatment Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Women age 18 70 Patient life condition &lt; 2 ( WHO scale ) Onesided breast adenocarcinoma histological evidence ( type ) Clinical presentation allow complete surgery healthy limit Absence metastasis detectable clinical examination radiology Histological evidence homolateral axillary ganglionic invasion , whatever number node invade ( N &gt; 1 ) The beginning chemotherapy within 6 week follow primary surgery All metastatic affect Tumor class &gt; = T4a : cutaneous invasion , deep adherence , inflammatory breast All chemotherapy , hormonotherapy radiotherapy surgery Tumoral residue remove Any suspect clinic radiologic lesion , contralateral breast , control History invasive neoplasm , mammary ( except situ carcinoma cervix uteri epithelioma )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>genomic signature</keyword>
	<keyword>lymph node</keyword>
	<keyword>metastasis</keyword>
</DOC>